NIHR Bristol Biomedical Research Centre (Nutrition Theme), Level 3, University Hospitals Bristol Education and Research Centre, Upper Maudlin Street, Bristol, BS2 8AE, UK.
J Cancer Surviv. 2020 Oct;14(5):624-642. doi: 10.1007/s11764-020-00871-1. Epub 2020 Jul 18.
To collate evidence of changes in body composition following treatment of leukaemia in children, teenagers and young adults (CTYA, 0-24 years) with allogeneic haematopoietic stem cell transplant and total body irradiation (HSCT+TBI).
Papers were identified by searching Medline and Google Scholar, reference lists/citations and contacting key authors, with no date or language restrictions. Inclusion criteria were as follows: leukaemia, HSCT+TBI, aged ≤ 24 years at HSCT and changes in body composition (total fat, central adiposity, adipose tissue function, muscle mass, muscle function). Quality was assessed using a brief Newcastle-Ottawa scale.
Of 900 papers, 20 were included: seven controlled, five uncontrolled studies and eight case reports. Study quality appeared good. There was little evidence of differences in total fat/weight for HSCT + TBI groups (compared to healthy controls/population norms/short stature controls). There was some evidence of significantly higher central adiposity and differences in adipose tissue function (compared to leukaemic/non-leukaemic controls). Muscle mass was significantly lower (compared to healthy/obese controls). Muscle function results were inconclusive but suggested impairment. Case reports confirmed a lipodystrophic phenotype.
Early remodelling of adipose tissue and loss of skeletal muscle are evident following HSCT + TBI for CTYA leukaemia, with extreme phenotype of overt lipodystrophy. There is some evidence for reduced muscle effectiveness.
Body composition changes in patients after HSCT + TBI are apparent by early adult life and link with the risk of excess cardiometabolic morbidity seen in adult survivors. Interventions to improve muscle and/or adipose function, perhaps utilizing nutritional manipulation and/or targeted activity, should be investigated.
整理儿童、青少年和年轻成年人(CTYA,0-24 岁)接受异基因造血干细胞移植和全身照射(HSCT+TBI)治疗白血病后身体成分变化的证据。
通过搜索 Medline 和 Google Scholar、参考文献/引文以及联系主要作者来确定论文,无日期或语言限制。纳入标准如下:白血病、HSCT+TBI、HSCT 时年龄≤24 岁以及身体成分(总脂肪、中心肥胖、脂肪组织功能、肌肉量、肌肉功能)变化。使用简短的纽卡斯尔-渥太华量表评估质量。
在 900 篇论文中,有 20 篇被纳入:7 项对照研究、5 项非对照研究和 8 项病例报告。研究质量似乎很好。HSCT+TBI 组的总脂肪/体重差异几乎没有证据(与健康对照/人群正常值/矮小对照相比)。有一些证据表明中心肥胖程度较高,脂肪组织功能存在差异(与白血病/非白血病对照相比)。肌肉量明显较低(与健康/肥胖对照相比)。肌肉功能结果不确定,但提示存在损伤。病例报告证实了脂肪营养不良表型。
CTYA 白血病患者接受 HSCT+TBI 后,脂肪组织和骨骼肌早期重塑,表现为明显的脂肪营养不良表型。有一些证据表明肌肉效能降低。
HSCT+TBI 后患者的身体成分变化在成年早期就很明显,与成年幸存者中观察到的代谢并发症风险增加有关。应该研究改善肌肉和/或脂肪功能的干预措施,也许可以利用营养干预和/或靶向活动。